An army veteran and grandfather from Kent is the first in the world to be recruited to a study trialling a new treatment for ...

A new study finds that GLP-1 medications are linked to lower overall cancer risk, particularly for endometrial and ovarian ...

A groundbreaking study at Vanderbilt University Medical Center (VUMC) is changing the face of kidney cancer treatment.Doctors ...

A targeted cancer drug niraparib, used in combination with hormone therapy, was found to reduce the risk of prostate tumor ...

By targeting a newly uncovered weakness in prostate cancer cells, this could offer an improved treatment for the disease.

Researchers in Sweden are testing a 250-year-old medicine in patients with one of the world's deadliest cancers.

The FDA-approved Inluriyo, an oral estrogen receptor antagonist from Eli Lilly, has shown to achieve significant improvement ...

Pfizer (PFE) stock is in focus as a Phase 3 trial for its Tukysa cancer drug as a first-line maintenance option in ...

Xencor (NASDAQ:XNCR) shares lost ~13% on Tuesday as the company refuted concerns over an upcoming data readout from an early-stage trial for its kidney cancer drug, XmAb819, scheduled to be presented ...

Continued drug shortages remain a possibility, and recent moves by the government could create or exacerbate cancer drug shortages.

Lung cancer is the leading cause of cancer deaths in the U.S., according to the American Cancer Society. For people battling ...

LONDON (Reuters) -German biotech firm Tubulis said on Wednesday it had raised 308 million euros ($358 million) in its biggest ...